Whitebox Advisors’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-75,246
| Closed | -$759K | – | 731 |
|
|
2022
Q4 | $759K | Hold |
75,246
| – | – | 0.02% | 306 |
|
|
2022
Q3 | $746K | Hold |
75,246
| – | – | 0.02% | 400 |
|
|
2022
Q2 | $738K | Hold |
75,246
| – | – | 0.02% | 399 |
|
|
2022
Q1 | $738K | Sell |
75,246
-6,000
| -7% | -$58.8K | 0.01% | 427 |
|
|
2021
Q4 | $790K | Buy |
81,246
+6,246
| +8% | +$60.7K | 0.02% | 380 |
|
|
2021
Q3 | $727K | Hold |
75,000
| – | – | 0.02% | 350 |
|
|
2021
Q2 | $725K | Buy |
+75,000
| New | +$725K | 0.01% | 302 |
|